CN107929563A - 强力天麻杜仲胶囊及其成分检测方法 - Google Patents
强力天麻杜仲胶囊及其成分检测方法 Download PDFInfo
- Publication number
- CN107929563A CN107929563A CN201711380905.6A CN201711380905A CN107929563A CN 107929563 A CN107929563 A CN 107929563A CN 201711380905 A CN201711380905 A CN 201711380905A CN 107929563 A CN107929563 A CN 107929563A
- Authority
- CN
- China
- Prior art keywords
- capsule
- gastrodia elata
- strength
- solution
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 48
- 241000305492 Gastrodia Species 0.000 title claims abstract description 35
- 238000001514 detection method Methods 0.000 title claims description 9
- 241000208688 Eucommia Species 0.000 claims abstract description 18
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 13
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 13
- 235000014066 European mistletoe Nutrition 0.000 claims abstract description 13
- 241000244355 Ligusticum Species 0.000 claims abstract description 13
- 241000405414 Rehmannia Species 0.000 claims abstract description 13
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims abstract description 13
- 241000221012 Viscum Species 0.000 claims abstract description 13
- 229940023019 aconite Drugs 0.000 claims abstract description 13
- 241000212321 Levisticum Species 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 18
- 239000013558 reference substance Substances 0.000 claims description 18
- 239000012085 test solution Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 claims description 10
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 claims description 10
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000004587 chromatography analysis Methods 0.000 claims description 9
- 241000227129 Aconitum Species 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 244000269722 Thea sinensis Species 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000011630 iodine Substances 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 claims description 4
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 229930193974 gastrodin Natural products 0.000 claims description 4
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 claims description 4
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 210000002435 tendon Anatomy 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000036407 pain Effects 0.000 abstract description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 3
- 206010019233 Headaches Diseases 0.000 abstract description 3
- 208000006011 Stroke Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 231100000869 headache Toxicity 0.000 abstract description 3
- 231100000862 numbness Toxicity 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001516470 Cypripedium acaule Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Plasma & Fusion (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各中药组份的含量为:天麻120~150g、盐制杜仲130~160g、制草乌12~22g、制附子12~22g、羌活150~185g、独活70~95g、藁本90~110g、当归150~185g、地黄250~285g、玄参90~110g、川牛膝90~110g、槲寄生90~110g。上述各中药组份通过特定的制备方法获得强力天麻杜仲胶囊,该胶囊通过成分鉴别和检测,重复性和稳定性都非常好。本发明强力天麻杜仲胶囊具有散风活血,舒筋止痛的功效;可用于中风引起的筋脉掣痛,肢体麻木,行走不便,腰腿酸痛,头痛头昏等。
Description
技术领域
本发明属于中医药领域,特别涉及一种强力天麻杜仲胶囊及其成分检测方法。
背景技术
天麻又名赤箭、离母、鬼督邮、神草、独摇芝等等,是著名的中药材,其富含天麻素,香荚兰素,蛋白质,氨基酸,微量元素,具有抗癫痫,抗悸厥,抗风湿;镇静,镇痉,镇痛,补虚,平肝息风的功效。天麻的药用价值和食用营养价值都很高。
杜仲又名胶木,其游离氨基酸极少,含有的少量蛋白质,是和绝大多数食品类似的完全蛋白,即能够水解晰出对人体必需的8种氨基酸。杜仲中含有15种矿物元素,其中有锌、铜、铁等微量元素,及钙、磷、钾、镁等宏量元素。
中药中所说的杜仲是指杜仲的干燥树皮,味甘,性温。有补益肝肾、强筋壮骨、调理冲任、固经安胎的功效。可治疗肾阳虚引起的腰腿痛或酸软无力,肝气虚引起的胞胎不固,阴囊湿痒等症,是一种名贵的滋补药材。
中医是中华民族的国粹,各种中药材都具有不同的功效,但怎样将不同的中药材组合在一起达到相应的疗效,则是非常有讲究的。
发明内容
本发明的目的是根据天麻和杜仲的医用疗效,提供一种疗效显著、服用方便的强力天麻杜仲胶囊及其成分检测方法。
一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各中药组份的含量为:天麻 120~150g、盐制杜仲130~160g、制草乌12~22g、制附子12~22g、羌活150~185g、独活70~95g、藁本90~110g、当归150~185g、地黄 250~285g、玄参90~110g、川牛膝90~110g、槲寄生90~110g;
采用上述组份制备天麻杜仲胶囊的方法为:
(1)根据需要用量将各组份称量备用;
(2)将备好的天麻粉碎成细粉,过120目筛,备用;
(3)将备好的独活、藁本、当归、羌活提取挥发油,药渣留存备用;
(4)将步骤(3)所得药渣与杜仲、制草乌、附子、地黄、玄参、川牛膝、槲寄生混合均匀,加水煎煮2次,第一次3小时,第二次2小时,合并煎液,滤过,滤液浓缩成膏,备用;
(5)将步骤(2)所得天麻细粉与步骤(4)所得中药膏混合均匀干燥,粉碎,过筛,制成颗粒;
(6)将所得颗粒喷入步骤(3)制得的挥发油,混匀后装入胶囊,即得强力天麻杜仲胶囊。
进一步,按1000粒胶囊量计算,各中药组份的含量为:天麻139g、盐制杜仲147g、制草乌17g、制附子17g、羌活174g、独活86g、藁本102g、当归174g、地黄278g、玄参102g、川牛膝102g、槲寄生102g 。
强力天麻杜仲胶囊的成分可采用以下一种或一种以上方法进行鉴别:
(1)取本品内容物0.4克,以水浸渍3次,每次约2ml,浸渍10分钟;残渣置显微镜下,再以水洗除有色残液,见棕色组织碎块,加碘液0.02mol/L染色3~5分钟,染成茶棕色,再用水洗除碘液,则部分组织碎块边缘或部分菲薄组织碎块呈紫堇色或茶紫色;
(2)取本品内容物3.2g加约15ml乙醚及约1ml氨试液,充分搅拌或者振摇5分钟,静置10分钟,取上层醚液,挥干,加稀硫酸0.5ml、水2ml使溶解,滤过,取滤液1ml加碘化铋钾试液1滴,生成橙色沉淀;另取滤液1ml加碘-碘化钾试液1滴,生成棕色沉淀;
(3)取本品内容物4g,加饱和的正丁醇30ml,超声处理30分钟,滤过,滤液蒸干,残渣加水2ml使溶解,加在已处理好的D-101型大孔吸附树脂柱上,用10%乙醇25ml洗脱,蒸干,残渣加甲醇1ml使溶解,作为供试品溶液;另取天麻素对照品,加甲醇制成每1ml含1mg的溶液,作为对照品溶液;照薄层色谱法试验,吸取上述溶液2~3ul,分别点于同一羧甲基纤维素钠为粘合剂的硅胶G薄层板上,以氯仿-醋酸乙酯-甲醇-甲酸8:1:3:0.1为展开剂,展开,取出,晾干,喷以10%磷钼酸乙醇溶液,在110摄氏度烘至斑点显色清晰,供试品色谱中,在与对照品色谱相应的位置上,显示相同颜色斑点。
强力天麻杜仲胶囊可采用以下方法进行含量测定:
色谱条件与系统适用性试验以十八烷基硅烷键合硅胶为填充剂,乙腈—0.05%磷酸溶液2:98;检测波长:210nm;柱温:室温;流速:1.0ml/min,理论塔板数按梓醇峰计算应不低于5000;
对照品溶液的制备:精密称取梓醇对照品适量,精密称定,用流动相溶解并稀释,制成1ml含50ug梓醇的对照溶液;
供试品溶液的制备:取本品内容物1g,精密称定,置于具塞锥形瓶中,精密加甲醇50ml,精密称定重量,密塞,加热回流提取1.5小时,放冷,加甲醇补足减失重量,摇匀,滤过,取续滤液10ml,蒸干,残渣用流动相溶解,转移至10ml量瓶中,并用流动相稀释至刻度,摇匀,滤过,取续滤液,即得供试品溶液;
测定法分别精密吸取对照品溶液与供试品溶液各10μl,注入液相色谱仪,测定,即得。
本发明强力天麻杜仲胶囊具有散风活血,舒筋止痛的功效。可用于中风引起的筋脉掣痛,肢体麻木,行走不便,腰腿酸痛,头痛头昏等。
具体实施方式
以下结合实施例对本发明进行描述,所举实施例只用于解释发明,并非用于限定本发明的范围。
实施例1
一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各组份的含量为:天麻 120g、杜仲(盐制)130g、制草乌12g、附子(制)12g、羌活150g、独活70g、藁本190g、当归150g、地黄 250g、玄参90g、川牛膝90g、槲寄生 90g。
采用上述组份制备天麻杜仲胶囊的方法为:
(1)根据需要用量将各组份称量备用;
(2)将备好的天麻粉碎成细粉,过120目筛,备用;
(3)将备好的独活、藁本、当归、羌活提取挥发油,药渣留存备用;
(4)将步骤(3)所得药渣与杜仲、制草乌、附子、地黄、玄参、川牛膝、槲寄生混合均匀,加水煎煮2次,第一次3小时,第二次2小时,合并煎液,滤过,滤液浓缩成膏,备用;
(5)将步骤(2)所得天麻细粉与步骤(4)所得中药膏混合均匀干燥,粉碎,过筛,制成颗粒;
(6)将所得颗粒喷入步骤(3)制得的挥发油,混匀后装入胶囊,即得强力天麻杜仲胶囊。
实施例2
一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各组份的含量为:天麻130g,杜仲(盐制)135g、制草乌15g、附子(制)15g、羌活160g、独活80g、藁本95g、当归165g、地黄265g、玄参95g、川牛膝95g、槲寄生95g。采用上述组份制备强力天麻杜仲胶囊的方法与实施例1相同。
实施例3
一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各组份的含量为:天麻139g、杜仲(盐制)147g、制草乌17g、附子(制)17g、羌活174g、独活86g、藁本102g、当归174g、地黄278g、玄参102g、川牛膝102g、槲寄生102g 。采用上述组份制备强力天麻杜仲胶囊的方法与实施例1相同。
实施例4
一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各组份的含量为:天麻145g、杜仲(盐制)155g、制草乌20g、附子(制)20g、羌活180g、独活90g、藁本105g、当归180g、地黄280g、玄参105、川牛膝105g、槲寄生105g。采用上述组份制备强力天麻杜仲胶囊的方法与实施例1相同。
实施例5
一种强力天麻杜仲胶囊,按1000粒胶囊量计算,各组份的含量为:天麻150g、杜仲(盐制)160g、制草乌22g、附子(制)22g、羌活185g、独活95g、藁本110g、当归185g、地黄285g、玄参110g、川牛膝110g、槲寄生110g。采用上述组份制备强力天麻杜仲胶囊的方法与实施例1相同。
对本发明强力天麻杜仲胶囊进行鉴别的方法如下:
(1)取本品内容物0.4克,以水浸渍3次,每次约2ml,浸渍10分钟。残渣置显微镜下,再以水洗除有色残液,见棕色组织碎块,加碘液(0.02mol/L)染色3~5分钟,染成茶棕色,再用水洗除碘液,则部分组织碎块边缘或部分菲薄组织碎块呈紫堇色或茶紫色。
(2)取本品内容物3.2g加约15ml乙醚及约1ml氨试液,充分搅拌或者振摇5分钟,静置10分钟,取上层醚液,挥干,加稀硫酸0.5ml、水2ml使溶解,滤过,取滤液1ml加碘化铋钾试液1滴,生成橙色沉淀;另取滤液1ml加碘-碘化钾试液1滴,生成棕色沉淀。
(3)取本品内容物4g,加饱和的正丁醇30ml,超声处理30分钟,滤过,滤液蒸干,残渣加水2ml使溶解,加在已处理好的D-101型大孔吸附树脂柱(柱长16cm,内径1cm)上,用10%乙醇25ml洗脱,蒸干,残渣加甲醇1ml使溶解,作为供试品溶液。另取天麻素对照品,加甲醇制成每1ml含1mg的溶液,作为对照品溶液。照薄层色谱法(《中国药典》2015年版四部通则0502)试验,吸取上述溶液2~3ul,分别点于同一羧甲基纤维素钠为粘合剂的硅胶G薄层板上,以氯仿-醋酸乙酯-甲醇-甲酸(8:1:3:0.1)为展开剂,展开,取出,晾干,喷以10%磷钼酸乙醇溶液,在110摄氏度烘至斑点显色清晰,供试品色谱中,在与对照品色谱相应的位置上,显示相同颜色斑点。
对本发明强力天麻杜仲胶囊进行含量测定,确保强力天麻杜仲胶囊每粒(0.4g)含梓醇不低于0.12mg,采用照液相色谱法(《中国药典》2015年版四部通则0512)测定。
色谱条件与系统适用性试验以十八烷基硅烷键合硅胶为填充剂,乙腈—0.05%磷酸溶液(2::98);检测波长:210nm;柱温:室温;流速:1.0ml/min,理论塔板数按梓醇峰计算应不低于5000;
(1)对照品溶液的制备:精密称取梓醇对照品适量,精密称定,用流动相溶解并稀释,制成1ml含50ug梓醇的对照溶液;
(2)供试品溶液的制备:取本品内容物1g,精密称定,置于具塞锥形瓶中,精密加甲醇50ml,精密称定重量,密塞,加热回流提取1.5小时,放冷,加甲醇补足减失重量,摇匀,滤过,取续滤液10ml,蒸干,残渣用流动相溶解,转移至10ml量瓶中,并用流动相稀释至刻度,摇匀,滤过,取续滤液,即得供试品溶液。
测定法分别精密吸取对照品溶液与供试品溶液各10μl,注入液相色谱仪,测定,即得。
测定时将6份供试品溶液各10μl,注入液相色谱仪,测定峰面积,计算结果如下表,梓醇的平均含量为0.2764mg/g,RSD为1.54%。
通过上表可看出,每粒强力天麻杜仲胶囊(0.4g/粒)中梓醇的含量均不低于0.12mg,试品之间梓醇的含量偏差小于2%,重复性良好。本发明强力天麻杜仲胶囊具有散风活血,舒筋止痛的功效。可用于治疗中风引起的筋脉掣痛,肢体麻木,行走不便,腰腿酸痛,头痛头昏等。本发明采用口服形式,一次2~3粒,一日两次;须密封保存。
Claims (4)
1.一种强力天麻杜仲胶囊,其特征在于:按1000粒胶囊量计算,各中药组份的含量为:天麻 120~150g、盐制杜仲130~160g、制草乌12~22g、制附子12~22g、羌活150~185g、独活70~95g、藁本90~110g、当归150~185g、地黄 250~285g、玄参90~110g、川牛膝90~110g、槲寄生 90~110g;
采用上述组份制备天麻杜仲胶囊的方法为:
(1)根据需要用量将各组份称量备用;
(2)将备好的天麻粉碎成细粉,过120目筛,备用;
(3)将备好的独活、藁本、当归、羌活提取挥发油,药渣留存备用;
(4)将步骤(3)所得药渣与杜仲、制草乌、附子、地黄、玄参、川牛膝、槲寄生混合均匀,加水煎煮2次,第一次3小时,第二次2小时,合并煎液,滤过,滤液浓缩成膏,备用;
(5)将步骤(2)所得天麻细粉与步骤(4)所得中药膏混合均匀干燥,粉碎,过筛,制成颗粒;
(6)将所得颗粒喷入步骤(3)制得的挥发油,混匀后装入胶囊,即得强力天麻杜仲胶囊。
2.如权利要求1所述强力天麻杜仲胶囊,其特征在于:按1000粒胶囊量计算,各中药组份的含量为:天麻139g、盐制杜仲147g、制草乌17g、制附子17g、羌活174g、独活86g、藁本102g、当归174g、地黄278g、玄参102g、川牛膝102g、槲寄生102g 。
3.如权利要求1或2所述强力天麻杜仲胶囊的成分检测方法,其特征在于:采用以下一种或一种以上方法进行鉴别:
(1)取本品内容物0.4克,以水浸渍3次,每次约2ml,浸渍10分钟;残渣置显微镜下,再以水洗除有色残液,见棕色组织碎块,加碘液0.02mol/L染色3~5分钟,染成茶棕色,再用水洗除碘液,则部分组织碎块边缘或部分菲薄组织碎块呈紫堇色或茶紫色;
(2)取本品内容物3.2g加约15ml乙醚及约1ml氨试液,充分搅拌或者振摇5分钟,静置10分钟,取上层醚液,挥干,加稀硫酸0.5ml、水2ml使溶解,滤过,取滤液1ml加碘化铋钾试液1滴,生成橙色沉淀;另取滤液1ml加碘-碘化钾试液1滴,生成棕色沉淀;
(3)取本品内容物4g,加饱和的正丁醇30ml,超声处理30分钟,滤过,滤液蒸干,残渣加水2ml使溶解,加在已处理好的D-101型大孔吸附树脂柱上,用10%乙醇25ml洗脱,蒸干,残渣加甲醇1ml使溶解,作为供试品溶液;另取天麻素对照品,加甲醇制成每1ml含1mg的溶液,作为对照品溶液;照薄层色谱法试验,吸取上述溶液2~3ul,分别点于同一羧甲基纤维素钠为粘合剂的硅胶G薄层板上,以氯仿-醋酸乙酯-甲醇-甲酸8:1:3:0.1为展开剂,展开,取出,晾干,喷以10%磷钼酸乙醇溶液,在110℃烘至斑点显色清晰,供试品色谱中,在与对照品色谱相应的位置上,显示相同颜色斑点。
4.如权利要求3所述强力天麻杜仲胶囊的成分检测方法,其特征在于:采用以下方法进行含量测定:
色谱条件与系统适用性试验以十八烷基硅烷键合硅胶为填充剂,乙腈—0.05%磷酸溶液2:98;检测波长:210nm;柱温:室温;流速:1.0ml/min,理论塔板数按梓醇峰计算应不低于5000;
对照品溶液的制备:精密称取梓醇对照品适量,精密称定,用流动相溶解并稀释,制成1ml含50ug梓醇的对照溶液;
供试品溶液的制备:取本品内容物1g,精密称定,置于具塞锥形瓶中,精密加甲醇50ml,精密称定重量,密塞,加热回流提取1.5小时,放冷,加甲醇补足减失重量,摇匀,滤过,取续滤液10ml,蒸干,残渣用流动相溶解,转移至10ml量瓶中,并用流动相稀释至刻度,摇匀,滤过,取续滤液,即得供试品溶液;
测定法分别精密吸取对照品溶液与供试品溶液各10μl,注入液相色谱仪,测定,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711380905.6A CN107929563A (zh) | 2017-12-20 | 2017-12-20 | 强力天麻杜仲胶囊及其成分检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711380905.6A CN107929563A (zh) | 2017-12-20 | 2017-12-20 | 强力天麻杜仲胶囊及其成分检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107929563A true CN107929563A (zh) | 2018-04-20 |
Family
ID=61941347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711380905.6A Pending CN107929563A (zh) | 2017-12-20 | 2017-12-20 | 强力天麻杜仲胶囊及其成分检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107929563A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109893608A (zh) * | 2019-04-03 | 2019-06-18 | 吉林省精鑫药业集团有限公司 | 一种中成药天麻胶囊内容物的制备方法 |
CN113769023A (zh) * | 2021-09-23 | 2021-12-10 | 江苏省中医院 | 一种治疗高血压的中药复方组合物及其质量检测方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374118A (zh) * | 2002-03-22 | 2002-10-16 | 通化利民药业有限责任公司 | 一种治疗筋脉掣痛和肢体麻木的中药及制作工艺 |
CN1528436A (zh) * | 2003-10-09 | 2004-09-15 | 贵州三力制药有限责任公司 | 以天麻杜仲为主要原料的中药制剂及其制备方法 |
CN1537571A (zh) * | 2003-04-15 | 2004-10-20 | 毛友昌 | 强力天麻杜仲颗粒及制备方法 |
CN101745035A (zh) * | 2009-12-04 | 2010-06-23 | 贵阳春科药业技术研发有限公司 | 治疗中风的胶囊制剂的质量控制方法 |
KR20130047778A (ko) * | 2011-10-25 | 2013-05-09 | (주)아모레퍼시픽 | 약용 꽃을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물 |
CN105596788A (zh) * | 2010-12-17 | 2016-05-25 | 贵州三力制药有限责任公司 | 一种防治脑血管疾病的药物制剂及其制备方法 |
-
2017
- 2017-12-20 CN CN201711380905.6A patent/CN107929563A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374118A (zh) * | 2002-03-22 | 2002-10-16 | 通化利民药业有限责任公司 | 一种治疗筋脉掣痛和肢体麻木的中药及制作工艺 |
CN1537571A (zh) * | 2003-04-15 | 2004-10-20 | 毛友昌 | 强力天麻杜仲颗粒及制备方法 |
CN1528436A (zh) * | 2003-10-09 | 2004-09-15 | 贵州三力制药有限责任公司 | 以天麻杜仲为主要原料的中药制剂及其制备方法 |
CN101745035A (zh) * | 2009-12-04 | 2010-06-23 | 贵阳春科药业技术研发有限公司 | 治疗中风的胶囊制剂的质量控制方法 |
CN105596788A (zh) * | 2010-12-17 | 2016-05-25 | 贵州三力制药有限责任公司 | 一种防治脑血管疾病的药物制剂及其制备方法 |
KR20130047778A (ko) * | 2011-10-25 | 2013-05-09 | (주)아모레퍼시픽 | 약용 꽃을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물 |
Non-Patent Citations (4)
Title |
---|
吴钟琪等: "《医学临床"三基"训练.药师分册》", 31 December 2011, 湖南科学技术出版社 * |
国家药典委员会: "《中华人民共和国药典临床用药须知:2015年版.中药饮片卷》", 30 September 2017, 中国医药科技出版社 * |
张锦等: "强力天麻杜仲胶囊中6味药材的薄层色谱鉴别", 《中国药业》 * |
杨培民等: "高效液相色谱法测定地黄叶中梓醇的含量", 《现代中药研究与实践》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109893608A (zh) * | 2019-04-03 | 2019-06-18 | 吉林省精鑫药业集团有限公司 | 一种中成药天麻胶囊内容物的制备方法 |
CN113769023A (zh) * | 2021-09-23 | 2021-12-10 | 江苏省中医院 | 一种治疗高血压的中药复方组合物及其质量检测方法 |
CN113769023B (zh) * | 2021-09-23 | 2023-09-05 | 江苏省中医院 | 一种治疗高血压的中药复方组合物及其质量检测方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062128B (zh) | 芍药总苷提取物及其制备方法 | |
CN102657823B (zh) | 一种具有抗癌作用的中药组合物及其制备方法和检测方法 | |
CN102688431A (zh) | 一种补肾口服液及其制备方法 | |
CN102145106B (zh) | 一种治疗骨质疏松症的中药组合物及补肾活血颗粒剂 | |
CN107929563A (zh) | 强力天麻杜仲胶囊及其成分检测方法 | |
CN100438903C (zh) | 中药制剂的质量控制方法 | |
CN109908200A (zh) | 一种丹参药材的炮制加工方法 | |
CN105031005A (zh) | 一种补气益血的微丸 | |
CN103405632B (zh) | 一种玄麦参甲口服液及其制备方法和质量标准的检测方法 | |
CN110441407A (zh) | 一种泽术片质量控制方法 | |
CN103211907A (zh) | 四物汤复方配方颗粒及其制备方法和检测方法 | |
CN105982970A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN100402059C (zh) | 舒筋定痛制剂的质量控制方法 | |
CN101269182A (zh) | 一种治疗小儿风热感冒的药物组合物及制备方法和质量控制方法 | |
CN102590423B (zh) | 川芎茶调颗粒制剂指纹图谱的测定方法 | |
CN108254447B (zh) | 一种药物组合物的检测方法 | |
CN101564465A (zh) | 一种用于养血益气、调经温寒的中药组合物及其制备方法 | |
CN104034839A (zh) | 乙肝扶正胶囊的质量检测方法 | |
CN106511497A (zh) | 一种中药组合物及其制备方法 | |
CN104792918A (zh) | 一种男宝胶囊中驴肾的质量检测方法 | |
CN110448651A (zh) | 一种治疗肝病的藏中药组合物的制备方法、该组合物及包含其的颗粒剂 | |
CN104922649B (zh) | 姜黄消痤外用制剂及其制备方法和用途 | |
CN102846831B (zh) | 一种中药组合物及其制备方法和用途 | |
CN114646721B (zh) | 一种益脑通络中药组合物的质量检测方法 | |
CN103768494B (zh) | 一种治疗偏头痛的药物组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180420 |
|
RJ01 | Rejection of invention patent application after publication |